ūüďě  +1 (855) 661-4441(US)   ūüďě  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Anatomic Pathology Market Research Report Information, by Type (Instruments, Consumables and Services), by Application (Disease Diagnostic (Cancer, lymphoma and others), Drug Discovery and Developments) by end users (Hospitals, Clinical Laboratories and Physician Office Laboratory) - Global Forecast to 2032

ID: MRFR/LS/1779-HCR | 80 Pages | Author: Kinjoll Dey| July 2024

Anatomic Pathology Market Overview

Anatomic Pathology Market Size was valued at USD 40.28 Billion in 2023. The Anatomic Pathology industry is projected to grow from USD 43.14 Billion in 2024 to USD 74.80 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.15% during the forecast period (2024 - 2032). It has been seen that the world market is growing steadily in the forecast period. Anatomical pathology is also defined as a medical specialty or the commonwealth, which is concerned with diagnosing disease in terms of the microscopic, macroscopic, immunologic, biochemical, and molecular examination of tissues and organs. Anatomic pathology usually requires a physician who is trained in pathological diagnosis to do the processing, diagnosis, and examination of surgical examples.

In 2020, the services for anatomical pathology were accounted to hold the largest market share due to the growing incidence of cancer and other chronic diseases, continuous growth in the geriatric population, and reimbursements availability for diagnostic tests across the world. 

As per the anatomic pathology market outlook report, the current market consists of different intended audiences such as consumable manufacturers & suppliers, anatomic pathology instrument manufacturers & suppliers, research and development (R&D) companies, pathology service providers, government and independent regulatory authorities, contract research organizations (CROs), academic institutes and universities, government research laboratories, consulting and market research service providers, and independent research laboratories. 

COVID-19 Analysis 

Every aspect of the diagnostics industry has been impacted due to the coronavirus outbreak across the world. The Covid-19 pandemic had a profound impact on the patients who are going through treatment, diagnosis, and cancer screening. At this time, many diagnostic and treatment procedures got postponed or canceled across the globe, which has affected the global market. 

Moreover, the lockdown-related restrictions have delayed treatment and diagnosis of cancer patients, which has increased cancer mortality rates across the world. However, the anatomic pathology market players have worked harder to enhance the market growth during the forecast period. 

Anatomic Pathology Market Trends

  • Key Market Drivers

According to the World Health Organisation (WHO), cancer disease is the second-leading cause of death across the world, and nearly 19.3 million new cancer cases and 10 million deaths cases were accounted for in 2020 due to cancer. This is further projected to increase to 30.2 million by the end of the year 2040. Hence, the rising cases of cancer and other target diseases among the population are increasing the market demand for anatomic pathology in the research period. 

Moreover, the increasing support of the government to develop and innovate new advanced things for anatomic pathology is driving the market size during the research timeframe. 

  • Market Challenges 

The worldwide anatomic pathology market growth might experience challenges due to the availability of refurbished anatomic pathology instruments across the world. The refurbished anatomic pathology instruments like microtomes, staining systems, and tissue processors are provided by some of the prominent market players such as Rankin Biomedical Corporation (US), LabX (US), Swerdlick Medical Systems (US), and AL-TAR (US).

Moreover, the high cost associated with anatomic pathology might be one of the major challenges for the market of anatomic pathology during the assessment timeframe. 

  • Market Opportunities

In oncology drug trials, the anatomic pathology products and services are extensively used to detect morphological structures, analyze quantitative information, understand drug mechanisms and detect pharmacodynamic markers. Hence, the rising number of clinical trials pertaining to cancer drugs and any other drugs are estimated to bring lucrative market opportunities for the anatomic pathology.

Apart from this, the manufacturers and market players have more significant opportunities due to the rising investment, product innovation and ongoing R&D activities in the market for anatomic pathology.

  • Market Restraints 

The market of anatomic pathology might get affected due to the lack of professionals and physicians for anatomic pathology. 

Also, the high cost associated with anatomic pathology might hamper the growth of the market during the forecast period. 

Cumulative Evaluation of The Market 

As per the market trends report, significant growth has been seen in recent years and is expected to grow steadily in the upcoming years. 

Furthermore, the market value is effectively extending due to the continuous efforts of the key players. They are adopting new strategies and collaboration to maintain the market share in the further coming years.  

Anatomic Pathology Market Segmental Insights

The market of anatomic pathology is classified based on application, end-users and type.

anatomic pathology Application Insights:

In terms of the application segment, the market has been divided into medical research and development and disease diagnostics for diseases like lymphoma, cancer, and others.

Among these, the disease diagnostics segment is registered to account for the largest market share anatomic pathology during the year 2020. This segment is expanding due to the rising incidence of cancer and other chronic diseases and rapid growth in the geriatric population.

anatomic pathology type Insights

On the basis of type segment, the market of anatomic pathology has been segregated into consumables, instruments, and services. 

Here, the instrument type segment includes Slide Staining Systems, Cell Processors, Tissue Processing Systems, Coverslippers, Embedding Systems, Microtomes, and other instruments. Further, the consumable type segment is sub-segregated into antibodies (primary and secondary antibodies), probes, kits &reagents (fixatives, stains &solvents, and other kits &reagents) and other consumables. Moreover, the services segment is further divided into cytopathology and histopathology. 

anatomic pathology end-users Insights

Depending on the end-user segment, the market of anatomic pathology has been classified into physician office laboratories, clinical office laboratories, hospitals, and others.

In 2020, the hospital laboratories were registered to account for the largest anatomic pathology market share because of the rising awareness about early disease diagnosis, the growing number of patient visits to hospitals, and the increasing in-house diagnostic procedures performed in hospitals. Moreover, the availability of reimbursements for clinical tests in hospitals is projected to fuel the global market. 

anatomic pathology Regional Insights

Globally, the market of anatomic pathology has been divided into different geographical areas such as Asia Pacific, North America, Europe, and the rest of the world. 

The North American anatomic pathology market is projected to generate the largest market share for anatomic pathology during the research period due to the rising healthcare expenditure and increasing prevalence of chronicle diseases in the region. Moreover, the presence of major key players in the North American region is fuelling the global market growth during the review timeframe. Also, the increasing high-quality infrastructure for clinical laboratories and hospitals is driving the market growth in North America. 

Among these, the European anatomic pathology market is projected to be the second-largest market for anatomic pathology during the assessment period. This region is expanding due to the government initiatives for screening cancer patients and easy accessibility to new and advanced technology in the region. Further, the Asia pacific regional market is anticipated to be the fastest-growing market during the research timeframe.

Competitive Intensity Within the Industry  

According to the anatomic pathology market analysis, the prominent market players are working efficiently to compete with the other competitors to show their presence to the world. In this analysis report, the prominent key players profiled are:

  • Thermo Fisher Scientific,

  • AdnaGen,

  • Oxford Cancer Biomarkers,

  • Biocare Medical,

  • Tecan,

  • AutoGenomics,

  • Enzo Biochem,

  • Janssen Diagnostic,

  • Nucleix,

  • VolitionRx,

  • Abbott Diagnostics, 

  • Danaher, 

  • Roche Diagnostics, 

  • Abcam, 

  • Agilent Technologies,

  • Advanced Cell Diagnostics, 

  • Angsana Molecular & Diagnostics Laboratory, 

  • Biocartis, 

  • Cancer Genetics, 

  • CellMax Life, 

  • Digipath, 

  • Epic Sciences, 

  • Monogram Biosciences, 

  • Omnyx, 


The covered companies are playing an important role in the anatomic pathology market growth by giving their continuous support in innovating things. These players are focusing more on the research and developmental activities related to anatomic pathology. 

Recent Market Developments 

  • In January 2019, the prominent player PHC Holding Corporation finished the acquisition of Anatomical Pathology business with Thermo Fisher Scientific. It has aimed to strengthen and power its leading position in the segment of diagnostics.  

  • In May 2021, the FDA gave premarket approval (PMA) to the Hologic for its specimen transfer for downstream applications and ThinPrep GenesisTM processor for processing cytology.

Report Overview 

Presently, the global market has shown significant growth. Based on the anatomic pathology market forecast report, the global market has been segmented into applications, types and end-users. This report has also highlighted the market overview, market segmentation, regional classification, competitive landscape, recent development, and covid-19 analysis to get insight into the global market.

Moreover, this report is a combination of both qualitative and quantitative analysis that gives a better understanding of the market for anatomic pathology.

Anatomic Pathology Market Segmentation

anatomic pathology Application Outlook

  • medical research and development, 

  • disease diagnostics

anatomic pathology type Outlook

  • consumable, 

  • instruments, 

  • services

anatomic pathology end-users Outlook

  • physician office laboratory, 

  • clinical office laboratories, 

  • hospitals, 

  • others

Report Attribute/Metric Details
  Market Size   USD 74.81 Billion
  CAGR   7.15%
  Base Year   2023
  Forecast Period   2024-2032
  Historical Data   2021
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Application and End Users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Abbott Diagnostics, Agilent Technologies, Danaher, Roche Diagnostics, Thermo Fisher Scientific, Abcam, AdnaGen, Advanced Cell Diagnostics, Agendia, Angsana Molecular & Diagnostics Laboratory, AutoGenomics, Biocare Medical, Biocartis, CellMax Life, Cancer Genetics, Digipath, Enzo Biochem, Epic Sciences, Janssen Diagnostic, Monogram Biosciences, Nucleix, Omnyx, Oxford Cancer Biomarkers, RareCyte, SAKURA FINETEK USA, Tecan, and VolitionRx
  Key Market Opportunities   Joint ventures, strategic alliances, mergers and acquisitions
  Key Market Drivers   Increasing numbers of laboratory and pathological services

Frequently Asked Questions (FAQ) :

The valuation of the global anatomic pathology market is estimated to increase to USD 74.80 Billion by the end of 2032.

Increasing numbers of laboratory and pathological services, benefits extended by anatomic pathology in understanding the effect of diseases, developments in postmortem procedures, and augmenting demand for AP and molecular oncology services in healthcare are major drivers of the global anatomic pathology market.

North America holds the largest share in the global anatomic pathology market, followed by Europe and the Asia Pacific, respectively.

Oxford Cancer Biomarkers, Agilent Technologies, Abbott Diagnostics, Roche Diagnostics, Danaher, Abcam, Advanced Cell Diagnostics, Janssen Diagnostic, Agendia, SAKURA FINETEK USA, Thermo Fisher Scientific, Tecan, AutoGenomics, Angsana Molecular & Diagnostics Laboratory, Monogram Biosciences, Nucleix, Biocartis, CellMax Life, AdnaGen, Biocare Medical, Cancer Genetics, Enzo Biochem, Digipath, Epic Sciences, RareCyte, Omnyx, and VolitionRx., are some of the major players operating in the anatomic pathology market.

Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global anatomic pathology market adopt to gain a larger competitive advantage.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.